Shree Ganesh Remedies Complete Financial Statements
In FY2026, Shree Ganesh Remedies (SGRL) reported revenue ₹34 Cr, net profit ₹6 Cr and EPS ₹4.88, with a net profit margin of 17.6% and ROE of 3.7%. Full financial statements from FY2019 to FY2026 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Shree Ganesh Remedies stock price NSE.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
SGRL Revenue, Net Profit & EBITDA — Year-on-Year Growth
SGRL YoY (Mar 2025 vs Mar 2026) — revenue +25.9%, net profit -14.3%, expenses +46.7%. Explore Shree Ganesh Remedies intrinsic worth to estimate fundamental worth using multiple valuation models.
SGRL Income Statement — Revenue, EBITDA & Net Profit
Shree Ganesh Remedies revenue ₹34 Cr, EBITDA ₹12 Cr, net profit ₹6 Cr, EPS ₹4.88 (2026) — net profit margin 17.6%. Review SGRL price earnings ratio to evaluate earnings-based valuation against sector peers.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Jun 2020 | Dec 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 34 | 31 | 27 | 25 | 22 | 33 | 39 | 25 | 28 | 17 | 16 | 14 | 22 | 12 | 10 | 14 |
| Expenses | 22 | 21 | 15 | 17 | 14 | 21 | 20 | 17 | 17 | 13 | 10 | 10 | 15 | 7 | 8 | 10 |
| EBITDA | 12 | 10 | 12 | 8 | 7 | 12 | 18 | 9 | 11 | 5 | 5 | 4 | 7 | 5 | 2 | 4 |
| Operating Profit Margin % | 34.00% | 32.00% | 40.00% | 30.00% | 32.00% | 35.00% | 45.00% | 33.00% | 37.00% | 26.00% | 33.00% | 24.00% | 27.00% | 36.00% | 12.00% | 24.00% |
| Depreciation | 3 | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 9 | 7 | 9 | 5 | 4 | 9 | 16 | 6 | 8 | 4 | 4 | 3 | 6 | 4 | 1 | 4 |
| Tax | 3 | 2 | 2 | 1 | 1 | 2 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Profit | 6 | 5 | 7 | 4 | 3 | 6 | 13 | 5 | 5 | 3 | 3 | 2 | 4 | 3 | 1 | 3 |
| Earnings Per Share (₹) | 4.88 | 3.86 | 5.13 | 2.68 | 2.41 | 4.97 | 10.01 | 3.62 | 4.22 | 3.02 | 3.03 | 4.68 | 3.50 | 6.18 | 0.85 | 2.31 |
SGRL Balance Sheet — Assets, Liabilities & Shareholders' Equity
SGRL total assets ₹208 Cr, total equity ₹163 Cr, total liabilities ₹ Cr (2026) — ROE 3.7%.
| Particulars | 2026 | 2025 | 2024 | 2020 | 2019 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Total Assets | 208 | 192 | 171 | 55 | 41 |
| Current Assets | 86 | 78 | 70 | 34 | 26 |
| Fixed Assets | 118 | 95 | 81 | 20 | 15 |
| Capital Work in Progress | 12 | 9 | 17 | 0 | 0 |
| Investments | 24 | 18 | 5 | 3 | 4 |
| Other Assets | 0 | 70 | 69 | 32 | 23 |
| LIABILITIES | |||||
| Total Liabilities | |||||
| Current Liabilities | 23 | 31 | 30 | 3 | 1 |
| Non-Current Liabilities | |||||
| SHAREHOLDERS' EQUITY | |||||
| Total Equity | 163 | 145 | 122 | 42 | 34 |
| Share Capital | 13 | 13 | 13 | 9 | 9 |
| Reserves & Surplus | 150 | 132 | 109 | 33 | 25 |
SGRL Cash Flow Statement — Operating, Investing & Financing
Shree Ganesh Remedies operating cash flow ₹31 Cr, investing ₹-36 Cr, financing ₹-1 Cr, net cash flow ₹-6 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2020 | March 2019 |
|---|---|---|---|---|
| Operating Activities | 31 | 31 | 5 | -5 |
| Investing Activities | -36 | -33 | -3 | 0 |
| Financing Activities | -1 | 10 | -1 | 0 |
| Net Cash Flow | -6 | 7 | 1 | -6 |